Navigation Links
Sangamo Announces Public Offering of Common Stock
Date:4/7/2011

gamo also has a Phase 1/2 clinical trial and two ongoing Phase 1 clinical trials to evaluate safety and clinical effect of a treatment for HIV/AIDS as well as a Phase 1 trial of a treatment for recurrent glioblastoma multiforme. Other therapeutic development programs are focused on Parkinson's disease, monogenic diseases, neuropathic pain and nerve regeneration.  Sangamo's core competencies enable the engineering of a class of DNA-binding proteins called zinc finger DNA-binding proteins (ZFPs).  By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TFs) that can control gene expression and, consequently, cell function.  Sangamo is also developing sequence-specific ZFP Nucleases (ZFNs) for gene modification.  Sangamo has established strategic partnerships with companies in non-therapeutic applications of its technology including Dow AgroSciences and Sigma-Aldrich Corporation. For more information about Sangamo, visit the company's website at www.sangamo.com.

ZFP Therapeutic® is a registered trademark of Sangamo BioSciences, Inc.

This press release may contain forward-looking statements based on Sangamo's current expectations. These forward-looking statements include, without limitation, references to Sangamo's public offering of common stock, the anticipated timing of the closing of the offering, the research and development of novel ZFP TFs and ZFNs and therapeutic applications of Sangamo's ZFP technology platform. Actual results may differ materially from these forward-looking statements due to a number of factors, including, risks and uncertainties associated with market conditions and the satisfaction of customary closing conditions related to the proposed offering, technological challenges, Sangamo's ability to develop commercially viable products and technological developments by our competitors. See the company's SEC f
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sangamo BioSciences and CHDI Foundation Announce Collaboration to Develop ZFP Therapeutic® for Huntingtons Disease
2. Sangamo BioSciences Announces Presentation at the 10th Annual Needham Healthcare Conference
3. Sangamo BioSciences Reports Fourth Quarter and Full Year 2010 Financial Results
4. Sangamo BioSciences Announces Fourth Quarter and Full Year 2010 Conference Call and Webcast
5. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
6. Sangamo BioSciences Announces Data Presentation of First In Vivo Demonstration of ZFN-mediated Gene Correction Via Systemic Delivery at American Society for Hematology Meeting
7. Sangamo BioSciences Awarded Grants for the Development of Four ZFP Therapeutic® Programs
8. Sangamo BioSciences Announces Third Quarter 2010 Conference Call and Webcast
9. Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences
10. Sangamo BioSciences Announces Second Quarter 2010 Conference Call and Webcast
11. Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Regenestem Network has announced the grand ... Aires, Argentina. The clinic will be lead by Silvina ... assembled a multidisciplinary team of medical professionals who specialize ... Madero office. , The new Regenestem Network members ... studies in cellular therapies, and establish Regenestem protocols to ...
(Date:5/26/2015)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ) announced today ... provide an update on the progress of Sangamo,s ZFP Therapeutic ... business strategy at 1:30pm ET on Monday, June 1, 2015, ... being held in New York, NY . ... be accessed via a link on the Sangamo BioSciences website ...
(Date:5/26/2015)... NJ (PRWEB) May 26, 2015 OHAUS ... balances and scales, is set to release a new ... of quality-driven laboratory instruments. For over a century, the ... in weighing technology throughout the world. Now in ... has gone Beyond Weighing to include water quality measurement. ...
(Date:5/26/2015)... 2015 Kevin Xu , prezident ... Barackovi Obamovi a Billovi Clintonovi za ich kondolencie ... Rongxiang Xu , otca Kevina. ... Dr. Xu bol pionier, inovátor, humanitárny pracovník a ... oblasti vedy a príkladné vedenie svojej komunity zanecháva ...
Breaking Biology Technology:Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 2Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 3Sangamo BioSciences Announces Presentation At The Jefferies 2015 Global Healthcare Conference 2OHAUS Corporation to Release New Water Analysis Meters in 2015 2OHAUS Corporation to Release New Water Analysis Meters in 2015 3Dr. Rongxiang Xu, O legende 2
... Demonstrations at Biometrics Technology Expo will highlight a ... tools and service-oriented middleware, BEDFORD, Mass., Sept. ... of imaging and biometrics software, today,celebrates its long ... to the biometrics industry. Aware will,demonstrate a comprehensive ...
... INC. (Nasdaq: VION ) announced today that it ... Stearns Healthcare,Conference on Tuesday, September 11, 2007 at 4:30 ... Grand Hyatt Hotel in New York City and,the presentation ... the presentation will be posted to Vion,s website, http://www.vionpharm.com, ...
... Route to Administer GAMMAGARD LIQUID(TM) 10% Could Make, ... Up to $47 Million, DEERFIELD, Ill. and ... BAX ) and Halozyme Therapeutics, Inc.,(Nasdaq: ... an agreement to apply,Halozyme,s proprietary Enhanze(TM) Technology to ...
Cached Biology Technology:Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry 2Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry 3Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry 4Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry 5Vion Pharmaceuticals to Present at 20th Annual Bear Stearns Healthcare Conference 2Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology 2Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology 3Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology 4Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology 5Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology 6Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology 7
(Date:5/6/2015)... 2015 LifeBEAM, a developer of bio-sensing technology, ... today that they will expand their partnership in bio-sensing ... cycling helmet and the first joint project between the ... in order to give cyclists more style choices and ... and Lazer announced their plan to release a new ...
(Date:4/27/2015)... 27, 2015  For more than four decades, AUVSI,s ... been the premier worldwide event for the unmanned land, ... must-attend event for any local, national, or trade news ... commercial markets and current applications of unmanned technologies. The ... projected $48 billion industry, and how it will soon ...
(Date:4/27/2015)... LAUDERDALE, Fla. , Apr. 27, 2015 ... of access control and security systems is pleased to ... the company as a consultant and member of its ... is widely known as a thought leader in ... Distance Learning Technology Group, and has published studies and ...
Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... with the Environmental Services Unit at the Alejandro de Humboldt ... orchid. The Caribbean islands have been natural laboratories ... centuries now. Suffice to say that the studies by Charles ... to the emergence of the theory of evolution. ,In ...
... 27, 2012, Shenzhen, China - A Chinese research team, led ... Flowers Co., Ltd, and other institutes, has completed the first ... This work is extremely important for the deeper understanding of ... of fruit trees. The latest study was published online today ...
... MEDFORD/SOMERVILLE, Mass. (December, 26 2012) Tufts University School ... fabricating collagen structures that maintains the collagen,s natural strength ... of biomedical applications. Collagen, the most abundant protein ... for tissue engineering because it is biocompatible and biodegradable. ...
Cached Biology News:2 new species of orchid found in Cuba 22 new species of orchid found in Cuba 3The first genome sequence of Chinese plum provides important resource for fruit improvement 2The first genome sequence of Chinese plum provides important resource for fruit improvement 3Slice, stack, and roll: A new way to build collagen scaffolds 2
S. O'Hare & C.K. Atterwill • In vitro toxicity techniques for regular lab use. Ex vivo techniques are also covered with the aim of reducing and refining the use of animals in the future....
Agarase cleaves agarose to neoagaro-oligosaccharides, and is used for,quantitative, gentle recovery of DNA from low melting point agarose....
Form: Ready to use Applications: ELISA...
Form: Concentrated Applications: ELISA...
Biology Products: